Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 6;61(4):546-553.
doi: 10.1093/jrr/rraa038.

Linac-based fractionated stereotactic radiotherapy with a micro-multileaf collimator for large brain metastasis unsuitable for surgical resection

Ryosuke Matsuda  1 , Tetsuro Tamamoto  2 , Tadashi Sugimoto  3 , Shigeto Hontsu  4 , Kaori Yamaki  2 , Sachiko Miura  2 , Yasuhiro Takeshima  1 , Kentaro Tamura  1 , Shuichi Yamada  1 , Fumihiko Nishimura  1 , Ichiro Nakagawa  1 , Yasushi Motoyama  1 , Young-Su Park  1 , Hiroyuki Nakase  1 , Masatoshi Hasegawa  2
Affiliations

Linac-based fractionated stereotactic radiotherapy with a micro-multileaf collimator for large brain metastasis unsuitable for surgical resection

Ryosuke Matsuda et al. J Radiat Res. .

Abstract

The aim of this study was to assess clinical outcomes using linac-based, fractionated, stereotactic radiotherapy (fSRT) with a micro-multileaf collimator for large brain metastasis (LBM) unsuitable for surgical resection. Between January 2009 and October 2018 we treated 21 patients with LBM using linac-based fSRT. LBM was defined as a tumor with ≥30 mm maximal diameter in gadolinium-enhanced magnetic resonance images. LBMs originated from the lung (n = 17, 81%), ovary (n = 2, 9.5%), rectum (n = 1, 4.8%) and esophagus (n = 1, 4.8%). The median pretreatment Karnofsky performance status was 50 (range: 50-80). Recursive partition analysis (RPA) was as follows: Classes 2 and 3 were 7 and 14 patients, respectively. The median follow-up was 5 months (range: 1-86 months). The range of tumor volume was 8.7-26.5 cm3 (median: 17.1 cm3). All patients were basically treated with 35Gy in 5 fractions, except in three cases. The progression-free survival was 3.0 months. The median survival time was 7.0 months. There was no permanent radiation injury in any of the patients. Radiation-caused central nervous system necrosis, according to the Common Terminology Criteria for Adverse Events version 4.0, occurred in one patient (grade 3). One patients received bevacizumab for radiation necrosis. Two patients underwent additional surgical resection due to local progression and cyst formation. For patients with LBM unsuitable for surgical resection, linac-based fSRT is a promising therapeutic alternative.

Keywords: Novalis; fractionated radiotherapy; large brain metastasis; stereotactic radiotherapy.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Progression-free survival (A) and overall survival (B) estimated using the Kaplan–Meier method.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Wolf A, Kvint S, Chachoua A et al. . Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery. J Neurosurg 2018;128:23–31. - PubMed
    1. Ferguson SD, Wagner KM, Prabhu SS et al. . Neurosurgical management of brain metastases. Clin Exp Metastasis 2017;34:377–89. - PubMed
    1. Yomo S, Hayashi M, Nicholson C. A prospective pilot study of two-session gamma knife surgery for large metastatic brain tumors. J Neurooncol 2012;109:159–65. - PMC - PubMed
    1. Lee CC, Yen CP, Xu Z et al. . Large intracranial metastatic tumors treated by gamma knife surgery: Outcomes and prognostic factors. J Neurosurg 2014;120:52–9. - PubMed
    1. Hasegawa T, Kato T, Yamamoto T et al. . Multisession gamma knife surgery for large brain metastases. J Neurooncol 2017;131:517–24. - PubMed

MeSH terms